1. Microphysiometry to evaluate real-time response of mammary epithelial cells to IGF-I.
- Author
-
Robinson RM, Akers RM, and Forsten KE
- Subjects
- Animals, Cattle, Cell Division drug effects, Cell Line, Epithelial Cells drug effects, Epithelial Cells metabolism, Female, Hydrogen-Ion Concentration, Insulin-Like Growth Factor Binding Protein 3 drug effects, Insulin-Like Growth Factor Binding Protein 3 pharmacology, Mammary Glands, Animal cytology, Mammary Glands, Animal drug effects, Microchemistry instrumentation, Receptor, IGF Type 1 drug effects, Receptor, IGF Type 1 metabolism, Insulin-Like Growth Factor Binding Protein 3 metabolism, Insulin-Like Growth Factor I metabolism, Insulin-Like Growth Factor I pharmacology, Mammary Glands, Animal metabolism, Microchemistry methods
- Abstract
The Cytosensor Microphysiometer, a biosensor developed by Molecular Devices, was used to assay rapid binding activity of IGF-I for bovine mammary epithelial cell lines. Insulin-like growth factor-I (IGF-I) is a potent mitogen for mammary epithelial cells and has been implicated in breast cancer cell proliferation, a leading cause of cancer death of women in the U.S. today. IGF-I acts by binding to cell surface receptors. We are interested in how autocrine secretion might alter the activity and regulation of IGF-I. Real-time changes in excretion of protons, which we assert results from IGF-I binding, are detected by the Cytosensor Microphysiometer and can be correlated with cellular activity. We present IGF-I dose-dependent responses as well as correlated binding data to detect cell surface receptor concentration and thymidine incorporation results to determine cell proliferation following IGF-I stimulation. We examine the effect of insulin-like binding protein-3 (IGFBP-3) both in the presence and absence of IGF-I. We believe comparison of autocrine and paracrine environments for IGF-I stimulation, and the components contributing to the binding of IGF-I to the cell membrane receptor may provide pertinent information for the development of intervention schemes to slow or interrupt IGF-I binding to tumor cells and therefore cancer growth.
- Published
- 2000
- Full Text
- View/download PDF